| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ADA
|
adenosine deaminase
|
|
ADCYAP1
|
adenylate cyclase activating polypeptide 1 (pituitary)
|
|
ADCYAP1R1
|
adenylate cyclase activating polypeptide 1 (pituitary) receptor type I
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
AHSP
|
alpha hemoglobin stabilizing protein
|
|
AKR1C1
|
aldo-keto reductase family 1, member C1
|
|
AKR1C2
|
aldo-keto reductase family 1, member C2
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKR1C4
|
aldo-keto reductase family 1, member C4
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ANXA4
|
annexin A4
|
|
AR
|
androgen receptor
|
|
ATM
|
ATM serine/threonine kinase
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP15
|
bone morphogenetic protein 15
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMPR1A
|
bone morphogenetic protein receptor, type IA
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BSG
|
basigin (Ok blood group)
|
|
C10ORF10
|
chromosome 10 open reading frame 10
|
|
C3
|
complement component 3
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CALB2
|
calbindin 2
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CATSPER1
|
cation channel, sperm associated 1
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCNA2
|
cyclin A2
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCNG1
|
cyclin G1
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD151
|
CD151 molecule (Raph blood group)
|
|
CD1A
|
CD1a molecule
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CEBPD
|
CCAAT/enhancer binding protein (C/EBP), delta
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CHEK1
|
checkpoint kinase 1
|
|
CLDN3
|
claudin 3
|
|
CLDN4
|
claudin 4
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CRH
|
corticotropin releasing hormone
|
|
CRHR2
|
corticotropin releasing hormone receptor 2
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CSN2
|
casein beta
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CST6
|
cystatin E/M
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSB
|
cathepsin B
|
|
CTSL
|
cathepsin L
|
|
CUEDC2
|
CUE domain containing 2
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL14
|
chemokine (C-X-C motif) ligand 14
|
|
CXCL2
|
chemokine (C-X-C motif) ligand 2
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP27A1
|
cytochrome P450, family 27, subfamily A, polypeptide 1
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP4X1
|
cytochrome P450, family 4, subfamily X, polypeptide 1
|
|
CYP4Z1
|
cytochrome P450, family 4, subfamily Z, polypeptide 1
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
DEFB4A
|
defensin, beta 4A
|
|
DNAJA1
|
DnaJ (Hsp40) homolog, subfamily A, member 1
|
|
DNAJC7
|
DnaJ (Hsp40) homolog, subfamily C, member 7
|
|
E2F1
|
E2F transcription factor 1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
FAAH
|
fatty acid amide hydrolase
|
|
FBLN1
|
fibulin 1
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF4
|
fibroblast growth factor 4
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGR
|
FGR proto-oncogene, Src family tyrosine kinase
|
|
FKBP5
|
FK506 binding protein 5
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXO1
|
forkhead box O1
|
|
FSHB
|
follicle stimulating hormone, beta polypeptide
|
|
GABRA1
|
gamma-aminobutyric acid (GABA) A receptor, alpha 1
|
|
GABRB2
|
gamma-aminobutyric acid (GABA) A receptor, beta 2
|
|
GABRG2
|
gamma-aminobutyric acid (GABA) A receptor, gamma 2
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA3
|
GATA binding protein 3
|
|
GDF9
|
growth differentiation factor 9
|
|
GH1
|
growth hormone 1
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GLO1
|
glyoxalase I
|
|
GLRA1
|
glycine receptor, alpha 1
|
|
GLRB
|
glycine receptor, beta
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
|
GNRH2
|
gonadotropin-releasing hormone 2
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-F
|
major histocompatibility complex, class I, F
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD)
|
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HTRA3
|
HtrA serine peptidase 3
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFITM3
|
interferon induced transmembrane protein 3
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL17A
|
interleukin 17A
|
|
IL1B
|
interleukin 1, beta
|
|
IL27
|
interleukin 27
|
|
IL6
|
interleukin 6
|
|
INHA
|
inhibin, alpha
|
|
INHBA
|
inhibin, beta A
|
|
IRS1
|
insulin receptor substrate 1
|
|
IRS2
|
insulin receptor substrate 2
|
|
ITGA1
|
integrin, alpha 1
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JDP2
|
Jun dimerization protein 2
|
|
JUN
|
jun proto-oncogene
|
|
KAT7
|
K(lysine) acetyltransferase 7
|
|
KCNH1
|
potassium channel, voltage gated eag related subfamily H, member 1
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
|
KDM5A
|
lysine (K)-specific demethylase 5A
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF11
|
Kruppel-like factor 11
|
|
KLF13
|
Kruppel-like factor 13
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLF9
|
Kruppel-like factor 9
|
|
KLK14
|
kallikrein-related peptidase 14
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LHB
|
luteinizing hormone beta polypeptide
|
|
MACROD1
|
MACRO domain containing 1
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MATK
|
megakaryocyte-associated tyrosine kinase
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MIR155
|
microRNA 155
|
|
MIR15A
|
microRNA 15a
|
|
MIR200A
|
microRNA 200a
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MSI1
|
musashi RNA-binding protein 1
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
NCOA1
|
nuclear receptor coactivator 1
|
|
NCOR2
|
nuclear receptor corepressor 2
|
|
NCR3
|
natural cytotoxicity triggering receptor 3
|
|
NF1
|
neurofibromin 1
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NONO
|
non-POU domain containing, octamer-binding
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NR0B1
|
nuclear receptor subfamily 0, group B, member 1
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2
|
|
OXTR
|
oxytocin receptor
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PAQR5
|
progestin and adipoQ receptor family member V
|
|
PAQR6
|
progestin and adipoQ receptor family member VI
|
|
PAQR7
|
progestin and adipoQ receptor family member VII
|
|
PAQR8
|
progestin and adipoQ receptor family member VIII
|
|
PAQR9
|
progestin and adipoQ receptor family member IX
|
|
PAWR
|
PRKC, apoptosis, WT1, regulator
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PEBP4
|
phosphatidylethanolamine-binding protein 4
|
|
PGR
|
progesterone receptor
|
|
PGRMC1
|
progesterone receptor membrane component 1
|
|
PIAS4
|
protein inhibitor of activated STAT, 4
|
|
PIBF1
|
progesterone immunomodulatory binding factor 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
POMC
|
proopiomelanocortin
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PRL
|
prolactin
|
|
PRLR
|
prolactin receptor
|
|
PROS1
|
protein S (alpha)
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGER1
|
prostaglandin E receptor 1 (subtype EP1), 42kDa
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTX3
|
pentraxin 3, long
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RETN
|
resistin
|
|
RHOBTB2
|
Rho-related BTB domain containing 2
|
|
SCARB1
|
scavenger receptor class B, member 1
|
|
SCGB1A1
|
secretoglobin, family 1A, member 1 (uteroglobin)
|
|
SDC1
|
syndecan 1
|
|
SDC4
|
syndecan 4
|
|
SERPINA6
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6
|
|
SFN
|
stratifin
|
|
SFPQ
|
splicing factor proline/glutamine-rich
|
|
SGTA
|
small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha
|
|
SLC22A9
|
solute carrier family 22 (organic anion transporter), member 9
|
|
SLC8A1
|
solute carrier family 8 (sodium/calcium exchanger), member 1
|
|
SLCO2B1
|
solute carrier organic anion transporter family, member 2B1
|
|
SLPI
|
secretory leukocyte peptidase inhibitor
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SP1
|
Sp1 transcription factor
|
|
SRA1
|
steroid receptor RNA activator 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRD5A1
|
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)
|
|
STAR
|
steroidogenic acute regulatory protein
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STC1
|
stanniocalcin 1
|
|
STUB1
|
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase
|
|
SULT2B1
|
sulfotransferase family, cytosolic, 2B, member 1
|
|
TAC1
|
tachykinin, precursor 1
|
|
TCL1B
|
T-cell leukemia/lymphoma 1B
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB1I1
|
transforming growth factor beta 1 induced transcript 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
TGM2
|
transglutaminase 2
|
|
THBS1
|
thrombospondin 1
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TLR4
|
toll-like receptor 4
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TP53
|
tumor protein p53
|
|
TRERF1
|
transcriptional regulating factor 1
|
|
TRIM25
|
tripartite motif containing 25
|
|
TRPM3
|
transient receptor potential cation channel, subfamily M, member 3
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
|
TYMP
|
thymidine phosphorylase
|
|
UBR5
|
ubiquitin protein ligase E3 component n-recognin 5
|
|
UCN3
|
urocortin 3
|
|
UNC45A
|
unc-45 homolog A (C. elegans)
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
WBP2
|
WW domain binding protein 2
|
|
WT1
|
Wilms tumor 1
|
|
XRCC2
|
X-ray repair complementing defective repair in Chinese hamster cells 2
|
|
YAP1
|
Yes-associated protein 1
|
